Kenneth L. Mattox, MD, FACS
Program Director
Professor and Vice Chairman
Michael E. DeBakey Department of Surgery
Baylor College of Medicine
Houston, Texas
Eric R. Frykberg, MD, FACS
Professor of Surgery
University of Florida College of Medicine
Jacksonville, FL
Asher Hirshberg, MD, FACS
Director of Emergency Vascular Surgery
Kings County Hospital
Professor of Surgery
SUNY Downstate College of Medicine
New York, NY
Jorie Klein, RN
Trauma Program Manager
Parkland Memorial Hospital
Dallas, TX
Mary K. Allen, BS
Program Coordinator
Administrative Associate
Michael E. DeBakey Department of Surgery
Baylor College of Medicine
Houston, TX
Trauma, Vascular & Critical Care Surgeon
Royal London Hospital
University of London
London, England
Chairman, Department of Surgery
Rhode Island Hospital
Providence, RI
Associate Professor of Surgery
Uniformed Services University
Bethesda, MD
Assistant Professor of Surgery
Department of Surgery/Trauma/Critical Care
Tulane University Medical School
New Orleans, LA
Professor of Surgery
University of Florida College of Medicine
Jacksonville, FL
Director of Emergency Vascular Surgery
Kings County Hospital
Professor of Surgery
SUNY Downstate College of Medicine
New York, NY
Trauma Program Manager
Parkland Memorial Hospital
Dallas, TX
Deputy Assistant Secretary
Deputy Chief Medical Officer
Office of Health Affairs
Washington, D.C.
Professor & Vice Chair
Michael E. DeBakey Department of Surgery
Baylor College of Medicine
Chief of Staff & Chief of Surgery
Ben Taub General Hospital
Houston, TX
Professor of Surgery
Tulane University Medical School
New Orleans, LA
Medical Director
City of Houston EMS
Associate Professor of Emergency Medicine
Baylor College of Medicine
Houston, TX
Director of Trauma Services
Rabin Medical Center
Tel-Aviv, Israel
Assistant Professor of Surgery
University of Texas Health Science Center
San Antonio, TX
Professor of Surgery
Chief of Pediatric Surgery
University of Oklahoma College of Medicine
Oklahoma City, OK
In order to comply with the ACCME's Updated Standards for Commercial Support, The American College of Surgeons, as the accredited provider for this meeting, has implemented a new disclosure process to ensure that anyone who is in a position to control the content of the educational activity has disclosed all relevant financial relationships with any commercial interest as it pertains to the content of the presentation. The ACCME defines a "commercial interest" as any proprietary entity producing health care goods or services consumed by, or used on patients. It does not consider providers of clinical service directly to patients to be commercial interests. The ACS considers "relevant" financial relationships as financial transactions (in any amount) occurring within the past 12 months that may create a conflict of interest.
The updated standards also require that ACS manage any reported conflict and eliminate the potential for bias during the session. The planning committee members (if applicable) and speakers were contacted and the conflicts listed below have been managed to our satisfaction. However, if you perceive a bias, please advise us of the circumstances on the evaluation.
Please note we have advised the speakers that it is their responsibility to disclose at the start of their presentation if they will be describing the use of a device, product, or drug that is not FDA approved or the off-label use of an approved device, product, or drug or unapproved usage.
The requirement for disclosure is not intended to imply any impropriety of such relationship, but simply to identify such relationships through full disclosure, and to allow the audience to form its own judgments regarding the presentation
